Grimes & Company »

Regulus Therapeutics shares owned by Grimes & Company

Quarter-by-quarter ownership of Regulus Therapeutics (RGLS) shares owned by Grimes & Company from 13F filings

Historical chart of Grimes & Company investment in Regulus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Regulus Therapeutics held by Grimes & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regulus Therapeutics by Grimes & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $30k 10k 2.88
2023-12-31 $13k 10k 1.28
2023-09-30 $14k 11k 1.37
2023-06-30 $15k 10k 1.47
2023-03-31 $8.8k 10k 0.85